rpoB Mutations are Associated with Variable Levels of Rifampin and Rifabutin Resistance in Mycobacterium tuberculosis
- PMID: 36465812
- PMCID: PMC9717584
- DOI: 10.2147/IDR.S386863
rpoB Mutations are Associated with Variable Levels of Rifampin and Rifabutin Resistance in Mycobacterium tuberculosis
Abstract
Objective: To assess the relationship between the variant rpoB mutations and the degree of rifampin (RIF)/rifabutin (RFB) resistance in Mycobacterium tuberculosis (M. tuberculosis).
Methods: We analyzed the whole rpoB gene in 177 M. tuberculosis clinical isolates and quantified their minimum inhibitory concentrations (MICs) using microplate-based assays.
Results: The results revealed that of the 177 isolates, 116 were resistant to both RIF and RFB. There were 38 mutated patterns within the sequenced whole rpoB gene of the 120 isolates. Statistical analysis indicated that mutations, S450L, H445D, H445Y, and H445R, were associated with RIF and RFB resistance. Of these mutations, S450L, H445D, and H445Y were associated with high-level RIF and RFB MIC. H445R was associated with high-level RIF MIC, but not high-level RFB MIC. D435V and L452P were associated with only RIF, but not RFB resistance. Q432K and Q432L were associated with high-level RFB MIC. Several single mutations without statistical association with rifamycin resistance, such as V170F, occurred exclusively in low-level RIF but high-level RFB resistant isolates. Additionally, although cross-resistance to RIF and RFB is common, 21 RIF-resistant/RFB-susceptible isolates were identified.
Conclusion: This study highlighted the complexity of rifamycin resistance. Identification of the rpoB polymorphism will be helpful to diagnose the RIF-resistant tuberculosis that has the potential to benefit from a treatment regimen including RFB.
Keywords: Mycobacterium tuberculosis; mutation; rifabutin resistance; rifampin resistance.
© 2022 Li et al.
Conflict of interest statement
All authors have no competing interests to report in this work.
Similar articles
-
Rifampin-resistance-associated mutations in the rifampin-resistance-determining region of the rpoB gene of Mycobacterium tuberculosis clinical isolates in Shanghai, PR China.J Med Microbiol. 2021 Mar;70(3). doi: 10.1099/jmm.0.001317. Epub 2021 Jan 28. J Med Microbiol. 2021. PMID: 33507146
-
The beginning of the rpoB gene in addition to the rifampin resistance determination region might be needed for identifying rifampin/rifabutin cross-resistance in multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.J Clin Microbiol. 2012 Jan;50(1):81-5. doi: 10.1128/JCM.05092-11. Epub 2011 Nov 9. J Clin Microbiol. 2012. PMID: 22075601 Free PMC article.
-
rpoB Mutations and Effects on Rifampin Resistance in Mycobacterium tuberculosis.Infect Drug Resist. 2021 Oct 5;14:4119-4128. doi: 10.2147/IDR.S333433. eCollection 2021. Infect Drug Resist. 2021. PMID: 34675557 Free PMC article.
-
Association between the rifampicin resistance mutations and rifabutin susceptibility in Mycobacterium tuberculosis: A meta-analysis.J Glob Antimicrob Resist. 2025 Jan;40:53-61. doi: 10.1016/j.jgar.2024.11.014. Epub 2024 Nov 29. J Glob Antimicrob Resist. 2025. PMID: 39617268 Review.
-
Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis.J Infect Public Health. 2018 Sep-Oct;11(5):605-610. doi: 10.1016/j.jiph.2018.04.005. Epub 2018 Apr 26. J Infect Public Health. 2018. PMID: 29706316 Review.
Cited by
-
RpoB mutation patterns in Rifampicin-resistant tuberculosis: a Jiangxi Province study, 2021-2023.Sci Rep. 2025 Jul 31;15(1):27988. doi: 10.1038/s41598-025-11949-0. Sci Rep. 2025. PMID: 40745428 Free PMC article.
-
Discordance Between Phenotypic and WGS-Based Drug Susceptibility Testing Results for Some Anti-Tuberculosis Drugs: A Snapshot Study of Paired Mycobacterium tuberculosis Isolates with Small Genetic Distance.Infect Drug Resist. 2024 Aug 1;17:3289-3307. doi: 10.2147/IDR.S468997. eCollection 2024. Infect Drug Resist. 2024. PMID: 39108991 Free PMC article.
-
Discordant results between Xpert MTB/RIF assay and Bactec MGIT 960 culture system regarding the detection of rifampin-resistant Mycobacterium tuberculosis isolates in Wenzhou, China.Microbiol Spectr. 2024 Jun 4;12(6):e0385923. doi: 10.1128/spectrum.03859-23. Epub 2024 May 13. Microbiol Spectr. 2024. PMID: 38738892 Free PMC article.
-
Speeding up drug susceptibility testing in Mycobacterium tuberculosis using RNA biomarkers.EBioMedicine. 2025 Mar;113:105611. doi: 10.1016/j.ebiom.2025.105611. Epub 2025 Feb 25. EBioMedicine. 2025. PMID: 40010155 Free PMC article.
-
Comparison of targeted next-generation sequencing and the Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis in clinical isolates and sputum specimens.Microbiol Spectr. 2024 May 2;12(5):e0409823. doi: 10.1128/spectrum.04098-23. Epub 2024 Apr 11. Microbiol Spectr. 2024. PMID: 38602399 Free PMC article.
References
-
- World Health Organization. Global Tuberculosis Report 2022. Geneva: World Health Organization; 2022. licence: cc bY-Nc-sa 3.0 iGo.
LinkOut - more resources
Full Text Sources
Molecular Biology Databases